Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference

Journal of Infectious Diseases

Volumn 198, Issue 6, 2008, Pages 899-906

  Trautner, Barbara W ^a,b,c   Cevallos, Manuel E ^a   Li, Huaiguang ^a   Riosa, Sarah ^a   Hull, Richard A ^a   Hull, Sheila I ^a   Tweardy, David J ^a   Darouiche, Rabih O ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c N1319 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM MUTANT; CONTROLLED STUDY; EPITHELIUM CELL; FIM GENE; FIMBRIA; GENE EXPRESSION; NONHUMAN; PLASMID; PRIORITY JOURNAL; URINARY CATHETER; UROPATHOGENIC ESCHERICHIA COLI; UROTHELIUM; WILD TYPE;

ANTIBIOSIS; BACTERIAL ADHESION; DNA, BACTERIAL; ESCHERICHIA COLI; FIMBRIAE, BACTERIAL; HUMANS; OPERON; PLASMIDS; SILICONES; URINARY CATHETERIZATION;

EID: 51749115132     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/591093     Document Type: Article

References (41)

1. Darouiche R. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 2001; 33:1567-72.
2. Richards M, Edwards J, Culver D, Gaynes R. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21:510-5.
3. Tambyah P, Maki D. Catheter-associated urinary tract infection is rarely symptomatic. Arch Intern Med 2000; 160:678-82.
4. Warren J, Tenney J, Hoopes J, Muncle H, Anthony W. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982; 146:719-23.
5. Warren J. Catheter-associated urinary tract infections. Int J Antimicrob Agents 2001; 17:299-303.
6. Morris N, Stickler D, McLean R. The development of bacterial biofilms on indwelling urethral catheters. World J Urol 1999; 17:345-50.
7. Donlan R. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 8:881-90.
8. Reid G, Howard L. Effect on uropathogens of prophylaxis for urinary tract infection in spinal cord injured patients: preliminary study. Spinal Cord 1997; 35:605-7.
9. Warren J, Anthony W, Hoopes J, Muncie H. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA 1982; 248:454-8.
10. Gribble M, Puterman M. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med 1993; 95:141-52.
11. Prevention and management of urinary tract infections in paralyzed persons. Summary, evidence report/technology assessment: Number 6. Vol. 2006. Rockville, MD: Agency for Health Care Policy and Research, 1999.
12. Sprunt K, Leidy G. The use of bacterial interference to prevent infection. Can J Microbiol 1988; 34:332-8.
13. Bibel D. Bacterial interference, bacteriotherapy, and bacterioprophylaxis. In: Aly R, Shinefield H, eds. Bacterial interference. Boca Raton, FL: CRC Press, 1982:1-12.
14. Darouiche R, Donovan W, Del Terzo M, Thornby J, Rudy D, Hull R. Pilot trial of bacterial interference for preventing urinary tract infection. Urology 2001; 58:339-44.
15. Darouiche R, Thornby J, Cerra-Stewart C, Donovan W, Hull R. Bacterial interference for preventing urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 2005; 41:1531-40.
16. Trautner BW, Hull RA, Thornby JI, Darouiche RO. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control Hosp Epidemiol 2007; 28:92-4.
17. Trautner B, Darouiche R, Hull R, Hull S, Thornby J. Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. J Urol 2002; 167:375-9.
18. Trautner B, Hull R, Darouiche R. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 2003; 61:1059-62.
19. Costerton J, Stewart P, Greenberg E. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22.
20. Schembri M, Klemm P. Biofilm formation in a hydrodynamic environment by novel FimH variants and ramifications for virulence. Infect Immun 2001; 69:1322-8.
21. Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun 2006; 74:781-5.
22. Minuth J, Musher D, Thorsteinsson S. Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis 1976; 133:14.
23. Svanborg Eden C, Hull R, Falkow S, Leffler H. Target cell specificity of wild-type E. coli and mutants and clones with genetically defined adhesins. Prog Food Nutr Sci 1983; 7:75-89.
24. Hull RA, Gill RE, Hsu P, Minshew BH, Falkow S. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun 1981; 33:933-8.
25. Orndorff PE, Falkow S. Organization and expression of genes responsible for type 1 piliation in Escherichia coli. J Bacteriol 1984; 159:736-44.
26. Shizuya H, Birren B, Kim UJ, et al. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc Natl Acad Sci U S A 1992; 89:8794-7.
27. Buchanan K, Falkow S, Hull RA, Hull SI. Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili. J Bacteriol 1985; 162:799-803.
28. Chang A, Cohen S. Construction and characterization of multicopy amplifiable DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol 1978; 134:1141-56.
29. Lin-Chao S, Chen W, Wong T. High copy number of the pUC plasmid results from a Rom/Rop-supressible point mutation in RNA II. Mol Microbiol 1992; 6:3385-93.
30. Miki T, Yasukochi T, Nagatani H, et al. Construction of a plasmid vector for the regulatable high level expression of eukaryotic genes in Escherichia coli: an application to overproduction of chicken lysozyme. Protein Eng 1987; 1:327-32.
31. Hull R, Donovan W, DelTerzo M, Stewart C, Rogers M, Darouiche R. Role of type 1 fimbria- and P fimbriae-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 2002; 70:6481-4.
32. Hull R, Rudy D, Donovan W, Wieser I, Stewart C, Darouiche R. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun 1999; 67:429-32.
33. Salit IE, Gotschlich EC. Hemagglutination by purified type I Escherichia coli pili. J Exp Med 1977; 146:1169-81.
34. Holden NJ, Totsika M, Mahler E, et al. Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology 2006; 152:1143-53.
35. Ctmethod. Methods 2001; 25:402-8.
36. Sherertz R, Raad I, Belani A, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28:76-82.
37. Roos V, Klemm P. Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun 2006; 74:3565-75.
38. Svanborg Eden C, Eriksson B, Hanson LA. Adhesion of Escherichia coli to human uroepithelial cells in vitro. Infection and Immunity 1977; 18:767-74.
39. Pratt L, Kolter R. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 1998; 30:285.
40. Sokurenko EV, Chesnokova V, Dykhuizen DE, et al. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A 1998; 95:8922-6.
41. Bergsten G, Wullt B, Schembri MA, Leijonhufvud I, Svanborg C. Do type 1 fimbriae promote inflammation in the human urinary tract? Cell Microbiol 2007; 9:1766-81.